查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602644

過敏治療藥物市場：按類型、治療方法、分銷管道分類 - 全球預測 2025-2030

Allergy Drugs Market by Type (Drug Allergy, Food Allergy, Inhaled Allergy), Treatment (Anti-allergy Drugs, Immunotherapy), Distribution Channels - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年過敏治療藥物市值為297.1億美元，預計到2024年將達到322.1億美元，複合年成長率為8.48%，到2030年將達到525.4億美元。

我們的過敏藥物涵蓋範圍廣泛，用於治療過敏反應的藥物，例如抗組織胺、皮質類固醇、減充血劑和腎上腺素。這些藥物治療不同類型的過敏，包括季節性過敏、食物過敏和過敏性氣喘。由於都市化、污染水平上升和飲食模式的改變，全世界過敏症盛行率不斷上升，支持了對這些藥物的需求。過敏藥物（非處方藥和處方藥）用於緩解打噴嚏、搔癢和腫脹等症狀。最終使用領域包括醫院、診所和家庭護理機構，並有多種給藥形式支持，例如口服錠劑、滴鼻劑、吸入器和洗劑。

主要市場統計
基準年[2023] 297.1億美元
預測年份 [2024] 322.1億美元
預測年份 [2030] 525.4億美元
複合年成長率（%） 8.48%

市場成長受到生物技術和基因研究不斷進步等因素的影響，這些進步有助於更新、更有效的過敏治療。此外，認知度和診斷率的提高也支持市場擴張。然而，市場面臨長期使用這些藥物帶來的副作用、先進藥物高成本以及新藥認證嚴格的監管要求等挑戰。拓展新興市場存在潛在機會，這些市場的醫療基礎設施正在改善，過敏意識也在增強。免疫療法和生物製藥的創新是公司可以重點研究的開拓領域。

公司可以根據遺傳傾向探索針對特定類型過敏的個人化醫療方法。此外，輸送機制還有創新的空間，包括更有效率和患者友善的給藥方法，例如自動注射器和基於奈米技術的輸送系統。過敏藥物市場是一個競爭市場，學名藥藥和品牌藥都在爭奪市場佔有率。專注於識別新過敏原和改善環境控制的研究工作可以進一步加強市場並為顯著的業務成長提供途徑。透過創新解決方案解決這些限制和挑戰對於持續擴展市場至關重要。

市場動態：揭示快速發展的過敏藥物市場的關鍵市場洞察

供需的動態交互作用正在改變過敏藥物市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球過敏流行率不斷上升
    • 加大過敏特異性藥物的開發力道
    • 對非處方藥的偏好日益增加
  • 市場限制因素
    • 對專利到期和學名藥競爭的擔憂
  • 市場機會
    • 免疫療法簡介和越來越多的給藥方法
    • 消費者對食物過敏的認知不斷增強
  • 市場挑戰
    • 過敏藥物替代品的可用性

波特五力：駕馭過敏藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解過敏藥物市場的外部影響

外部宏觀環境因素在影響過敏治療藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解過敏治療藥物市場的競爭狀況

過敏治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣過敏治療市場供應商的績效評估

FPNV 定位矩陣是評估過敏治療藥物市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了過敏治療藥物市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，過敏治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球過敏盛行率不斷上升
      • 加大過敏特異性藥物的開發力道
      • 非處方藥的普及率不斷上升
    • 抑制因素
      • 對專利到期和學名藥激烈競爭的擔憂
    • 機會
      • 免疫療法簡介與給藥方法的發展
      • 提高消費者對食品過敏的認知
    • 任務
      • 治療過敏的替代藥物的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章過敏治療藥物市場：依類型

  • 藥物過敏
  • 食物過敏
  • 吸入過敏

第7章依治療分類的過敏治療藥物市場

  • 抗過敏藥
    • 抗組織胺藥
    • 皮質類固醇
    • 白三烯抑制劑
  • 免疫療法
    • 皮下免疫治療 (SCIT)舌下免疫治療 (SLIT)

第8章過敏治療藥物市場（依通路）

  • 醫院藥房
  • 網路藥房
  • 零售藥局/藥局

第9章北美及南美過敏藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太過敏藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲過敏藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Allergy Therapeutics PLC
  • Astra Biotech GmbH
  • AstraZeneca PLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • HAL Allergy BV
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • LETI Pharma, SLU
  • Lupin Limited
  • Mylan NV by Viatris Inc.
  • Novartis AG
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • XOLAIR by F. Hoffmann-La Roche AG
Product Code: MRR-434CCDA051DF

The Allergy Drugs Market was valued at USD 29.71 billion in 2023, expected to reach USD 32.21 billion in 2024, and is projected to grow at a CAGR of 8.48%, to USD 52.54 billion by 2030.

The scope of allergy drugs encompasses a wide range of medications used to treat allergic reactions, including antihistamines, corticosteroids, decongestants, and epinephrine, among others. These drugs cater to various types of allergies such as seasonal allergies, food allergies, and allergic asthma. The necessity of these medications is underscored by the rising prevalence of allergies globally, driven by urbanization, increased pollution levels, and changing dietary patterns. In terms of application, allergy drugs are used in both over-the-counter and prescription forms to relieve symptoms like sneezing, itching, and swelling. End-use sectors include hospitals, clinics, and homecare settings, supported by a variety of delivery forms such as oral tablets, nasal sprays, inhalers, and lotions.

KEY MARKET STATISTICS
Base Year [2023] USD 29.71 billion
Estimated Year [2024] USD 32.21 billion
Forecast Year [2030] USD 52.54 billion
CAGR (%) 8.48%

Market growth is influenced by factors like continuous advancements in biotechnology and genetic research, which contribute to newer and more effective allergy treatments. Additionally, growing awareness and diagnosis rates further enhance market expansion. However, the market faces challenges such as side effects associated with long-term usage of these drugs, high costs of advanced medications, and stringent regulatory requirements for new drug approval. Potential opportunities exist in expanding into emerging markets where healthcare infrastructures are improving and awareness around allergies is rising. Innovations in immunotherapy and biologic drugs represent untapped areas where companies could focus research efforts.

Companies could explore personalized medicine approaches to target specific types of allergies based on genetic predispositions. Additionally, there is room for innovation in delivery mechanisms, such as more efficient and patient-friendly administration methods like auto-injectors or nanotechnology-based delivery systems. The nature of the allergy drugs market is competitive, with both generic and branded drugs vying for market share. Initiatives in research focused on identifying new allergens and improving environmental controls could further bolster the market and provide avenues for significant business growth. Addressing these limitations and challenges with innovative solutions is crucial for continued market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Drugs Market

The Allergy Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of allergy globally
    • Increasing development of allergy-specific drugs
    • Rise in prevalence towards over the counter drugs
  • Market Restraints
    • Concerns over patent expiration and extensive competition from generic drugs
  • Market Opportunities
    • Introduction of immunotherapy and development of increasing ways of administration
    • Rising consumer awareness on food allergies
  • Market Challenges
    • Availability of alternative drugs for allergy

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Drugs Market

A detailed market share analysis in the Allergy Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Drugs Market

A strategic analysis of the Allergy Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Drugs Market, highlighting leading vendors and their innovative profiles. These include Allergy Therapeutics PLC, Astra Biotech GmbH, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., LETI Pharma, S.L.U., Lupin Limited, Mylan N.V. by Viatris Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., and XOLAIR by F. Hoffmann-La Roche AG.

Market Segmentation & Coverage

This research report categorizes the Allergy Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Drug Allergy, Food Allergy, and Inhaled Allergy.
  • Based on Treatment, market is studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs is further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy is further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).
  • Based on Distribution Channels, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of allergy globally
      • 5.1.1.2. Increasing development of allergy-specific drugs
      • 5.1.1.3. Rise in prevalence towards over the counter drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
      • 5.1.3.2. Rising consumer awareness on food allergies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative drugs for allergy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Allergy Drugs Market, by Type

  • 6.1. Introduction
  • 6.2. Drug Allergy
  • 6.3. Food Allergy
  • 6.4. Inhaled Allergy

7. Allergy Drugs Market, by Treatment

  • 7.1. Introduction
  • 7.2. Anti-allergy Drugs
    • 7.2.1. Antihistamines
    • 7.2.2. Corticosteroids
    • 7.2.3. Leukotriene Inhibitors
  • 7.3. Immunotherapy
    • 7.3.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)

8. Allergy Drugs Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies & Drug Stores

9. Americas Allergy Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Allergy Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Allergy Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allergy Therapeutics PLC
  • 2. Astra Biotech GmbH
  • 3. AstraZeneca PLC
  • 4. Bayer AG
  • 5. GlaxoSmithKline PLC
  • 6. HAL Allergy B.V.
  • 7. Hikma Pharmaceuticals PLC
  • 8. Johnson & Johnson Services, Inc.
  • 9. LETI Pharma, S.L.U.
  • 10. Lupin Limited
  • 11. Mylan N.V. by Viatris Inc.
  • 12. Novartis AG
  • 13. Sanofi SA
  • 14. Teva Pharmaceutical Industries Ltd.
  • 15. XOLAIR by F. Hoffmann-La Roche AG

LIST OF FIGURES

  • FIGURE 1. ALLERGY DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGY DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ALLERGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALLERGY DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGY DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 233. ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. ALLERGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023